abstract |
The invention relates to halogen substituted imidazo [1,5-a] [1,2,4] triazolo [1,5d] [1,4]benzodiazepine derivatives of formula (I), and to their pharmaceutically acceptable acid addition salts. The compounds may be used for the treatment of cognitive enhancer, cognitive disorders, anxiety, Alzheimer's disease and schizophrenia. |